Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills
  1. Research Outputs

Dietary Isoflavones and Intestinal Microbiota: Metabolism and Transformation into Bioactive Compounds

Chapter
Publication Date:
2010
Short description:
Dietary Isoflavones and Intestinal Microbiota: Metabolism and Transformation into Bioactive Compounds / Rossi, M., Amaretti, A., Roncaglia, L., Leonardi, A., Raimondi, S. - In: Isoflavones: Biosynthesis, Occurrence and Health Effects / Melanie J. Thompson. - STAMPA. - 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA : Melanie J. Thompson, 2010. - ISBN 9781612090665. - pp. 137-161
abstract:
Edible plants provide the human with hundreds of non-nutritional phytochemicals which are recognized as beneficial, such as isoflavones. Likewise other polyphenols, isoflavones may undergo extensive transformations during passage through human digestive tract, especially in the colon, where members of the complex commensal microbiota are capable to carry out synergistically a broad range of metabolic transformations affecting the fate and the biological activity of phytochemicals. Diverse bacterial species occurring in the large intestine hydrolyze the glucose conjugated forms of isoflavones, releasing the corresponding aglycones, which may undergo further microbial conversions (especially reductions) giving rise to a wide spectrum of isoflavone-derived compounds. The end-products of microbial transformations are subjected to substantial person-to-person variation, reflecting the impact of the colonic microbiota, since intestinal bacteria may greatly increase or compromise the biological activity of dietary isoflavones. In fact, certain reduction products (e.g. S-equol) possess superior antioxidant and estrogen-like activities, while others are precursors for C-ring cleavage and lead to isoflavone degradation. Extensive research has been performed to characterize the intestinal bacteria which are responsible for isoflavones transformations. In particular, many efforts are being carried out to identify single bacteria that convert the major soy isoflavone daidzein into S-equol, in the perspective to enrich soy products with such a valuable isoflavone-derived metabolite. Besides, diverse bacteria which are capable of deglycosylation, demethylation, and various reduction reactions are increasingly being identified. Nonetheless, only bifidobacteria and lactobacilli, which produce β-glucosidase that hydrolyze isoflavone glycosides into the corresponding aglycones, are currently exploited to improve the biological activity of soymilk.
Iris type:
Capitolo/Saggio
Keywords:
isoflavones; intestinal microbiota; biotransformation
List of contributors:
Rossi, Maddalena; Amaretti, Alberto; Roncaglia, Lucia; Leonardi, Alan; Raimondi, Stefano
Authors of the University:
AMARETTI Alberto
LEONARDI Alan
RAIMONDI Stefano
ROSSI Maddalena
Handle:
https://iris.unimore.it/handle/11380/646199
Full Text:
https://iris.unimore.it//retrieve/handle/11380/646199/38982/2010%20Isoflavones%20Chapter.pdf
Book title:
Isoflavones: Biosynthesis, Occurrence and Health Effects
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.7.0.0-SNAPSHOT